Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $480.68 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $191.68 | 10 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.31 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $93.85 | 3 | $0 (2020) |
| Indivior Inc. | $25.70 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.08 | 1 | $0 (2020) |
| Adlon Therapeutics L.P. | $22.06 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.31 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($124.31) |
| 2020 | $135.80 | 5 | Janssen Pharmaceuticals, Inc ($66.82) |
| 2019 | $68.40 | 3 | Janssen Pharmaceuticals, Inc ($27.03) |
| 2018 | $63.14 | 3 | Alkermes, Inc. ($63.14) |
| 2017 | $89.03 | 5 | Alkermes, Inc. ($89.03) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.31 | General |
| 12/15/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA, INVEGA TRINZA | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Neuroscience | ||||||
| 05/14/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 05/08/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $38.91 | General |
| Category: Neuroscience | ||||||
| 03/10/2020 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: CNS | ||||||
| 12/09/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: OUD | ||||||
| 07/16/2019 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: CNS | ||||||
| 05/02/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Neuroscience | ||||||
| 08/29/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: CNS | ||||||
| 03/29/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: CNS | ||||||
| 02/21/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: CNS | ||||||
| 12/04/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: CNS | ||||||
| 07/24/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: CNS | ||||||
| 06/06/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: CNS | ||||||
| 04/12/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: CNS | ||||||
| 02/06/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: CNS | ||||||
About Dr. Mark Hrymoc, MD
Dr. Mark Hrymoc, MD is a Addiction Psychiatry healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225118045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Hrymoc, MD has received a total of $480.68 in payments from pharmaceutical and medical device companies, with $124.31 received in 2024. These payments were reported across 17 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($480.68).
Practice Information
- Specialty Addiction Psychiatry
- Other Specialties Psychiatry
- Location Los Angeles, CA
- Active Since 10/16/2006
- Last Updated 01/20/2021
- Taxonomy Code 2084P0802X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225118045
Products in Payments
- Vivitrol 380 mg (Drug) $152.17
- SPRAVATO (Drug) $93.85
- SUBLOCADE (Drug) $25.70
- Vivitrol (Drug) $23.84
- TRINTELLIX (Drug) $23.08
- ADHANSIA XR (Drug) $22.06
- VIVITROL (Drug) $15.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction Psychiatry Doctors in Los Angeles
Jason Barrett
Addiction Psychiatry — Payments: $5,055
Dr. James Luzano
Addiction Psychiatry — Payments: $844.04
Rachel Knight, Md, MD
Addiction Psychiatry — Payments: $242.98
Brian Hurley, Md, Mba, MD, MBA
Addiction Psychiatry — Payments: $216.09
Dr. Jessica Jeffrey, Md, Mph, Mba, MD, MPH, MBA
Addiction Psychiatry — Payments: $98.05
Dr. Leandro Gatus, M.d, M.D
Addiction Psychiatry